| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Tenofovir | FAERS: 8 | US FAERS | |
| 2 | Tenofovir | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | GS-7340 | FAERS: 2 | US FAERS | |
| 4 | Telbivudine | FAERS: 2 | US FAERS | |
| 5 | adefovir dipivoxil | FAERS: 2 | OFFSIDES US FAERS | |
| 6 | entecavir | FAERS: 2 | US FAERS | |
| 7 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 8 | Emtricitabine, Rilpivirine, Tenofovir Drug Combination | FAERS: 1 | US FAERS | |
| 9 | F8 protein, human | FAERS: 1 | US FAERS | |
| 10 | INCB018424 | FAERS: 1 | US FAERS | |
| 11 | Lamivudine | FAERS: 1 | US FAERS | |
| 12 | Sorafenib | FAERS: 1 | US FAERS | |
| 13 | Terbinafine | FAERS: 1 | US FAERS | |
| 14 | Sevelamer | OFFSIDES | ||
| 15 | Sevelamer | OFFSIDES | ||
| 16 | Terbinafine | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120267
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.